Stockscreener 앱 받기
2.7299
0.73%
-0.0201
전일 마감가:
$2.75
열려 있는:
$2.77
하루 거래량:
17,587
Relative Volume:
0.10
시가총액:
$102.67M
수익:
-
순이익/손실:
$-13.27M
주가수익비율:
-16.65
EPS:
-0.164
순현금흐름:
$-7.70M
1주 성능:
-3.20%
1개월 성능:
+11.42%
6개월 성능:
+163.50%
1년 성능:
+100.58%
1일 변동 폭
$2.65
$2.77
1주일 범위
$2.65
$2.8482
52주 변동 폭
$0.8075
$3.11
Okyo Pharma Limited Stock (OKYO) Company Profile
OKYO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OKYO
Okyo Pharma Limited
|
2.7299 | 103.43M | 0 | -13.27M | -7.70M | -0.164 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.02 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.70 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.10 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
594.96 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.82 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Okyo Pharma Limited 주식(OKYO)의 최신 뉴스
Should I hold or sell OKYO Pharma Limited stock in 2025Capitalize on market shifts before others do - jammulinksnews.com
How does OKYO Pharma Limited compare to its industry peersMaximize your returns with expert insights - jammulinksnews.com
Analyzing OKYO Pharma Limited with risk reward ratio chartsFree Growth Based Stock Signal Screener - Newser
What is OKYO Pharma Limited company’s growth strategyAchieve consistent double-digit returns - jammulinksnews.com
What are the latest earnings results for OKYO Pharma LimitedTransform your portfolio with high-yield stocks - jammulinksnews.com
Is it the right time to buy OKYO Pharma Limited stockSky-high profits - jammulinksnews.com
What markets is OKYO Pharma Limited expanding into Is BAYA stock a good long term investment option - jammulinksnews.com
What are OKYO Pharma Limited company’s key revenue driversMaximize gains with proven stock analysis - jammulinksnews.com
What catalysts could drive OKYO Pharma Limited stock higher in 2025Free Stock Selection - jammulinksnews.com
What is the risk reward ratio of investing in OKYO Pharma Limited stockInvest smarter with real-time trading alerts - jammulinksnews.com
Published on: 2025-07-27 19:17:36 - jammulinksnews.com
How Resilient Is OKYO Pharma Limited Stock During Economic DownturnsFast Moving Stock Alerts - Newser
Why OKYO Pharma Limited stock attracts strong analyst attentionMarket Beating Strategy - Newser
How OKYO Pharma Limited stock performs during market volatilityControlled Risk High Reward Plan - Newser
OKYO Pharma Limited Stock Analysis and ForecastMarket-beating returns - PrintWeekIndia
What analysts say about OKYO Pharma Limited stockMassive stock growth - PrintWeekIndia
What institutions are buying OKYO Pharma Limited stock nowFree Market Dynamics Reports - jammulinksnews.com
Will OKYO Pharma Limited stock benefit from AI tech trendsExplosive market performance - jammulinksnews.com
OKYO Pharma reports promising phase 2 results for urcosimod in neuropathic corneal pain - Pharmafile
What drives OKYO Pharma Limited stock priceAccelerated wealth expansion - Autocar Professional
Is OKYO Pharma Limited a good long term investmentPhenomenal trading returns - Autocar Professional
OKYO Pharma Secures $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain - VisionMonday.com
Okyo Pharma Limited (OKYO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.09%
1.02%
자본화:
|
볼륨(24시간):